BRIEF published on 06/01/2026 at 22:10, 1 month 12 days ago European Commission Approves Amgen's IMDYLLTRA® for Lung Cancer Treatment Clinical Trial Results Amgen IMDYLLTRA Approval Small Cell Lung Cancer T-cell Engager Therapy
BRIEF published on 06/01/2026 at 22:10, 1 month 12 days ago La Commission européenne approuve l'IMDYLLTRA® d'Amgen pour le traitement du cancer du poumon Résultats Des Essais Cliniques Amgen Approbation IMDYLLTRA Cancer Du Poumon À Petites Cellules Thérapie D'activation Des Lymphocytes T
PRESS RELEASE published on 06/01/2026 at 22:05, 1 month 12 days ago EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER The European Commission has approved Amgen's IMDYLLTRA as a monotherapy for treating extensive-stage small cell lung cancer with a significant survival benefit over chemotherapy European Commission Approval Amgen Small Cell Lung Cancer IMDYLLTRA
BRIEF published on 02/12/2026 at 15:56, 5 months 1 day ago European Commission Approves Amgen's UPLIZNA® for Generalized Myasthenia Gravis European Commission Amgen UPLIZNA GMG CD19-targeted Therapy
BRIEF published on 02/12/2026 at 15:56, 5 months 1 day ago La Commission européenne approuve UPLIZNA® d'Amgen pour le traitement de la myasthénie grave généralisée Commission Européenne Amgen UPLIZNA GMG Thérapie Ciblée CD19
PRESS RELEASE published on 02/12/2026 at 15:51, 5 months 1 day ago EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS European Commission approves Amgen's UPLIZNA for Generalized Myasthenia Gravis. New targeted treatment option with twice-yearly dosing for gMG patients European Commission Treatment Amgen UPLIZNA Generalized Myasthenia Gravis
Published on 07/14/2026 at 01:45, 11 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 1 hour 55 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 2 hours 46 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 4 hours 21 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 5 hours 56 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 3 hours 26 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 4 hours 36 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 4 hours 38 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 5 hours 8 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 5 hours 33 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 7 hours 56 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 7 hours 56 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 7 hours 56 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
